|
|
||||||||
1 Department of Pharmacology, the Panum Institute, University of Copenhagen, 2200 Copenhagen N; and the 2 Department of Cell Biology, Institute of Anatomy, University of Arhus, Arhus DK-8000, Denmark
The present study was performed to investigate the renal
handling of water in rats with decompensated liver cirrhosis. Liver cirrhosis was induced by intraperitoneal administration of carbon tetrachloride twice weekly for 16 wk. Control rats were treated with
vehicle. The cirrhotic rats developed severe disturbances in water
homeostasis: urine production was decreased and hyperosmotic, the rats
had significantly decreased plasma sodium concentration and ascites,
and the ability to excrete an intravenous water load was significantly
impaired. Plasma concentrations of vasopressin and aldosterone were
increased. Mean arterial pressure, glomerular filtration rate (GFR),
and fractional lithium excretion were decreased. Acute vasopressin type
2-receptor blockade with the selective nonpeptide antagonist OPC-31260
(800 µg · kg
1 · h
1) was
performed during conditions whereby volume depletion was prevented by
computer-driven, servo-controlled intravenous volume replacement with
150 mM glucose. The aquaretic response to OPC-31260 was similar in
cirrhotic and control rats. However, the OPC 31260-induced rises in
fractional water excretion (
V/GFR; +24%) and fractional distal
water excretion (
V/CLi; +46%) were significantly
increased in the cirrhotic rats, where V is flow rate and
is
change. This suggests that vasopressin-mediated renal water
reabsorption capacity was increased in the cirrhotic rats.
Semiquantitative immunoblotting revealed that the expression of the
vasopressin-regulated water channel aquaporin-2 was unchanged in
membrane fractions of both whole kidney and inner medulla from
cirrhotic rats. Together, these results suggest a relative escape from
vasopressin on collecting duct water reabsorption in rats with
decompensated liver cirrhosis.
aquaporin-2; OPC-31260; collecting ducts; carbon tetrachloride; vasopressin type 2 receptor
This article has been cited by other articles:
![]() |
U. S. K. van Deurs, N. Hadrup, J. S. Petersen, S. Christensen, and T. E. N. Jonassen Nociceptin/Orphanin FQ Peptide Receptor Agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) Induces Antinatriuresis in Rats by Stimulation of Amiloride-Sensitive Sodium Reabsorption J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 533 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hadrup, J. S. Petersen, S. Windfeld, L. Risom, C. B. Andersen, S. Nielsen, S. Christensen, and T. E. N. Jonassen Differential Down-Regulation of Aquaporin-2 in Rat Kidney Zones by Peripheral Nociceptin/Orphanin FQ Receptor Agonism and Vasopressin Type-2 Receptor Antagonism J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 516 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Kim, U. K. Schou, C. D. Peters, S. de Seigneux, T.-H. Kwon, M. A. Knepper, T. E.N. Jonassen, J. Froki, and S. Nielsen Increased Apical Targeting of Renal Epithelial Sodium Channel Subunits and Decreased Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase in Rats with CCl4-Induced Decompensated Liver Cirrhosis J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3196 - 3210. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brond, N. Hadrup, N. Salling, M. Torp, M. Graebe, S. Christensen, S. Nielsen, and T. E. N. Jonassen Uncoupling of vasopressin signaling in collecting ducts from rats with CBL-induced liver cirrhosis Am J Physiol Renal Physiol, October 1, 2004; 287(4): F806 - F815. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hadrup, J. S. Petersen, J. Praetorius, E. Meier, M. Graebe, L. Brond, D. Staahltoft, S. Nielsen, S. Christensen, D. R. Kapusta, et al. Opioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulation Am J Physiol Renal Physiol, July 1, 2004; 287(1): F160 - F168. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. N. Jonassen, M. Grabe, D. Promeneur, S. Nielsen, S. Christensen, and N. V. Olsen Lipopolysaccharide-Induced Acute Renal Failure in Conscious Rats: Effects of Specific Phosphodiesterase Type 3 and 4 Inhibition J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 364 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Staahltoft, S. Nielsen, N. R. Janjua, S. Christensen, O. Skott, N. Marcussen, and T. E. N. Jonassen Losartan treatment normalizes renal sodium and water handling in rats with mild congestive heart failure Am J Physiol Renal Physiol, February 1, 2002; 282(2): F307 - F315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |